Oligo Hyaluronan‐Coated Silica/Hydroxyapatite Degradable Nanoparticles for Targeted Cancer Treatment

Targeted drug delivery systems (TDDSs) provide a promising approach to overcome the side effect of traditional chemotherapy by specific tumor targeting and drug release. Hyaluronan (HA), as a selective CD44 targeting group, has been widely used in TDDSs for chemotherapy. However, different molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yao, Sun, Wen, Li, Shuyi, Li, Mingle, Fan, Jiangli, Du, Jianjun, Liang, Xing‐Jie, Peng, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662421/
https://www.ncbi.nlm.nih.gov/pubmed/31380195
http://dx.doi.org/10.1002/advs.201900716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662421/
https://www.ncbi.nlm.nih.gov/pubmed/31380195
http://dx.doi.org/10.1002/advs.201900716

Ejemplares similares